A study for Efficacy and Safety of Metronomic Administration of Detoxification Chinese Herbs combined with Thalidomide in the Treatment of Elderly or Refractory Relapsed Lymphoma
- Conditions
- Relapsed or Refractory Non-Hodgkin's lymphoma
- Registration Number
- ITMCTR1900002282
- Lead Sponsor
- Shanghai Municiple hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Meet the pathological diagnostic criteria of lymphoma (pathological types are not limited);
2. Meet the diagnostic criteria for elderly or refractory or relapsed;
3. Patients assessed as inappropriate or intolerable or unwilling to receive combination chemotherapy and targeted therapy;
4. ECOG=3;
5. Survival is expected to be greater than 3 months;
6. Having signed the informed consent.
1. Aged<18 years;
2. Pregnant or lactating women;
3. History of thrombosis nearly 2 years;
4. Allergic or allergic to various drugs;
5. Severe liver and kidney dysfunction;
6. With severe infection or difficult to control;
7. Taking other traditional Chinese medicine or taking other clinical trials nearly 2 weeks;
8. The investigators concluded that patients should not take any other part of the study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of Life Assessment;TCM symptom score;VEGF;Tumor volume;
- Secondary Outcome Measures
Name Time Method ß2 microglobulin;LDH;